Amplatzer Amulet LAAO vs. NOAC

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 2650 participants.

Also called NCT04226547

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,650 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04226547
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Canada, Czechia, Denmark, France, Germany, Hong Kong SAR China, Italy, Japan, Lithuania, Netherlands, Poland, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04226547. Randomized; single masking; primary purpose treatment. Start 2020-07-07 (actual); primary completion 2029-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Amplatzer Amulet LAAO vs. NOAC
Acronym
CATALYST
Condition
Stroke
Condition
Bleeding
Intervention (Device)
Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder)
Intervention (Drug)
Non-Vitamin K Oral Antagonists
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct04226547
Content hash
6572d0c9912b76049398f9ec99157dc12475a88a59f00357fa0f396e21536f76